AVP-21D9

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2004-2017
01220042017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
BACKGROUND B. anthracis anti-toxin agents are approved and included in the Strategic National Stockpile based primarily on animal… (More)
  • figure 1
  • table 1
  • table 1
  • table 2
  • table 3
Is this relevant?
2014
2014
Anthrax is an acute infectious disease caused by the spore-forming bacterium Bacillus anthracis. Timely administration of… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
2007
2007
Dutch-belted and New Zealand White rabbits were passively immunized with AVP-21D9, a human monoclonal antibody to protective… (More)
Is this relevant?
2006
2006
Prevention of inhalation anthrax requires early and extended antibiotic therapy, and therefore, alternative treatment strategies… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2004
2004
BACKGROUND: Potent anthrax toxin neutralizing human monoclonal antibodies were generated from peripheral blood lymphocytes… (More)
  • table 1
  • table 2
Is this relevant?
2004
2004
A panel of human anti-anthrax protective antigen IgG1 monoclonal antibodies were evaluated to determine the mechanism of toxin… (More)
Is this relevant?